A way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health (NIH) and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The scientific efforts led by Salvemini, who is professor of pharmacological and physiological sciences at SLU, demonstrated that turning on a receptor in the brain and spinal cord counteracts chronic nerve pain in male and female rodents. Activating the A3 receptor – either by its native chemical stimulator, the small molecule adenosine, or by powerful synthetic small molecule drugs invented at the NIH – prevents or reverses pain that develops slowly from nerve damage without causing analgesic tolerance or intrinsic reward (unlike opioids).
An Unmet Medical Need
Pain is an enormous problem. As an unmet medical need, pain causes suffering and comes with a multi-billion dollar societal cost. Current treatments are problematic because they cause intolerable side effects, diminish quality of life and do not sufficiently quell pain.
The most successful pharmacological approaches for the treatment of chronic pain rely on certain “pathways”: circuits involving opioid, adrenergic, and calcium channels.
For the past decade, scientists have tried to take advantage of these known pathways – the series of interactions between molecular-level components that lead to pain. While adenosine had shown potential for pain-killing in humans, researchers had not yet successfully leveraged this particular pain pathway because the targeted receptors engaged many side effects.
A Key to Pain Relief
In this research, Salvemini and colleagues have demonstrated that activation of the A3 adenosine receptor subtype is key in mediating the pain relieving effects of adenosine.
“It has long been appreciated that harnessing the potent pain-killing effects of adenosine could provide a breakthrough step towards an effective treatment for chronic pain,” Salvemini said. “Our findings suggest that this goal may be achieved by focusing future work on the A3AR pathway, in particular, as its activation provides robust pain reduction across several types of pain.”
The Latest on: Pain relief
via Google News
The Latest on: Pain relief
- Why holding hands might help to reduce painon October 30, 2019 at 5:13 pm
Pain relief may be in the palm of your hand. New research suggests that physical touch, such as holding hands, could be helpful in reducing pain, most notably when it’s two people in a relationship, ...
- EicOsis Awarded SBIR Grant from the NCI/NIH to Evaluate the Potential of Drug Candidate, EC5026, to Treat Cancer-associated Painon October 30, 2019 at 5:03 pm
EC5026 is an orally active potent small molecule that has been shown to be highly efficacious for pain relief of both inflammatory and neuropathic pain in a variety of animal species. EicOsis will ...
- The Newest Form of Pain Relief During Labor? Virtual Realityon October 30, 2019 at 11:10 am
This means they often require higher doses to find relief. During labor, it’s possible that VR could offer a way to augment or replace medication to help manage pain for those with a substance use ...
- Finding relief from sciatica and spinal disorderson October 30, 2019 at 9:12 am
GRAND RAPIDS, Mich. (WOOD) – All around the world, back pain is the single leading cause of disability. Interfering with the way we work and live our daily lives. Many people who suffer from back pain ...
- Banks Count Cost of Negative Rates as ECB Tries to Ease Painon October 30, 2019 at 8:25 am
Deutsche Bank’s earnings and those of its European peers in the latest quarter underscored the pain they’re feeling after the European Central Bank pushed interest rates deeper into negative territory ...
- Bone Pain Treatment Market 2019 Exclusivity, Size, Share, Growth, Value, Trends, Segmentations, Top Mergers, and Forecast to 2022on October 30, 2019 at 6:59 am
Market Research Future has starting late imparted another examination to its wide research portfolio, which is titled as “Bone Pain Treatment Market Research Report- Global Forecast To 2022” gives an ...
- Pain Relief Centers Welcomes Dr. Thomas Reilly to Seminole Pain Clinicon October 30, 2019 at 3:00 am
he has helped thousands of patients find neck and back pain relief. He draws from a broad medical background and specialized training to treat chronic pain using a variety of minimally invasive ...
- Topical Pain Relief Market 2019: Business overview, Industry insights, Trends and Top Company Analysis Forecast by 2026on October 29, 2019 at 1:03 am
Oct 29, 2019 (Market Insight Reports via COMTEX) -- The research report published by Verified Market Research is a comprehensive study of the global Topical Pain Relief Market. The subject matter ...
- Could cannabis be a pain relief alternative to opioids?on October 28, 2019 at 5:52 am
How effective is cannabis as an alternative to opioids for pain relief? Many smaller clinical studies have shown cannabis is a viable alternative for pain relief for a variety of chronic conditions.
- Life’s a Pain: 7 Topical Pain Relief Products, Reviewedon October 25, 2019 at 3:27 pm
How this works. Welcome back to “Life’s a Pain!” This month’s topic is a touchy one: topicals. Today, there are a lot more options than the Bengay and IcyHot of my youth. I don’t leave the house ...
via Bing News